Detalhe da pesquisa
1.
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 401(10380): 917-927, 2023 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36842439
2.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol
; 24(6): 611-623, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37269842
3.
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lancet Oncol
; 23(12): e544-e551, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36455583
4.
Dietary fiber intake from fresh and preserved food and risk of nasopharyngeal carcinoma: observational evidence from a Chinese population.
Nutr J
; 20(1): 14, 2021 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33531022
5.
Standardization for oncologic head and neck surgery.
Eur Arch Otorhinolaryngol
; 278(12): 4663-4669, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33982178
6.
NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma.
Cancer
; 126(16): 3674-3688, 2020 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32497261
7.
Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma.
Br J Cancer
; 123(1): 114-125, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32372027
8.
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
Proc Natl Acad Sci U S A
; 113(40): 11283-11288, 2016 10 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27647909
9.
Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.
Proc Natl Acad Sci U S A
; 113(12): 3317-22, 2016 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26951679
10.
Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
Int J Cancer
; 143(9): 2289-2298, 2018 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29873071
11.
Head and neck cancer in Hong Kong.
Jpn J Clin Oncol
; 48(1): 13-21, 2018 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29145620
12.
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Cancer
; 123(21): 4147-4157, 2017 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28662313
13.
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma.
Lancet Oncol
; 22(6): e217, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34087127
14.
IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
Int J Cancer
; 138(1): 160-70, 2016 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26227166
15.
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Cancer
; 122(4): 546-58, 2016 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26588425
16.
Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Cancer
; 122(21): 3307-3315, 2016 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27434142
17.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Lancet Oncol
; 16(6): 645-55, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25957714
18.
Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Int J Cancer
; 136(4): E127-35, 2015 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25196065
19.
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
Cancer
; 121(8): 1328-38, 2015 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25529384
20.
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Cancer
; 121(16): 2720-9, 2015 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25946469